Remove 2020 Remove Access Remove Patients Remove Treatment
article thumbnail

Mississippi Becomes 37th State to Legalize Medical Cannabis With a Law that Provides Limited Access to Patients

Americans for Safe Access

In November 2020, Mississippi voters overwhelmingly supported a ballot initiative (74.1% Patients across the state should have equitable access to this treatment option and should not be burdened by localities that wrongly choose to opt out of the law. ASA strongly opposes both of these provisions.

Access 246
article thumbnail

Press Release: Cannabis Patient Care™ and Americans for Safe Access Form Partnership

Cannabis Law Report

Cannabis Patient Care™ launched in November 2020 and has already made a big impression in the medical cannabis community due to the quality of its content and the important message behind each issue,” said Mike Hennessy Jr.

Access 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.” ” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. percent in 2016).”

article thumbnail

Field Trip Aims To Help Patients Access Psilocybin and MDMA Through Health Canada

Cannabis Law Report

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. 01.015 of the FDR before providing the new drug to a patient. Timeline of Medicinal Legalization in Canada. Pursuant to subsection C.08.010(1)

Therapy 52
article thumbnail

FDA Expands Epidiolex Access for Those with Tuberous Sclerosis Complex

Veriheal

Up until March 2020, CBD was lumped in with cannabis as a Schedule I substance—highly addictive and with no accepted medical uses. Epidiolex was approved specifically for treating patients suffering from seizures associated with Dravet Syndrome, which is a severe form of epilepsy that affects between 20,000 and 40,000 people worldwide.

Access 98